Pyrazolopyridines as potent PDE4B inhibitors: 5-heterocycle SAR.
Mitchell, C.J., Ballantine, S.P., Coe, D.M., Cook, C.M., Delves, C.J., Dowle, M.D., Edlin, C.D., Hamblin, J.N., Holman, S., Johnson, M.R., Jones, P.S., Keeling, S.E., Kranz, M., Lindvall, M., Lucas, F.S., Neu, M., Solanke, Y.E., Somers, D.O., Trivedi, N.A., Wiseman, J.O.(2010) Bioorg Med Chem Lett 20: 5803-5806
- PubMed: 20732811 
- DOI: https://doi.org/10.1016/j.bmcl.2010.07.136
- Primary Citation of Related Structures:  
3O56, 3O57 - PubMed Abstract: 
Following the discovery of 4-(substituted amino)-1-alkyl-pyrazolo[3,4-b]pyridine-5-carboxamides as potent and selective phosphodiesterase 4B inhibitors, [Hamblin, J. N.; Angell, T.; Ballentine, S., et al. Bioorg. Med. Chem. Lett.2008, 18, 4237] the SAR of the 5-position was investigated further ...